HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Effects of buspirone in withdrawal from opiates.

Abstract
The purpose of this study is to evaluate the effectiveness of buspirone in attenuating withdrawal symptoms in heroin addicts and methadone-maintained patients following cessation of heroin or methadone use. Subjects were twenty hospitalized male chronic opiate users aged 30-55 who did not present any DSM-IV Axis I disorder with the exception of opioid dependence. For the first five days, patients received doses of methadone that were decreased to 30 mg and were maintained on this dose for the following three days. Methadone was then discontinued, and patients were randomly assigned to buspirone or placebo treatment from day nine to seventeen. The buspirone dose was 15 mg on day nine and 30 mg from day ten to day seventeen. Treatment was double-blind. Withdrawal symptoms were measured with the Objective Opiate Withdrawal Scale (OOWS) and the Subjective Opiate Withdrawal Scale (SOWS). Buspirone-treated patients had significantly lower scores on the OOWS on days thirteen (p=.040), fourteen (p=.025), fifteen (p=.035), and seventeen (p=.035). They also had lower scores on the SOWS on days sixteen (p=.050). It is concluded that buspirone was effective in attenuating the objective and subjective withdrawal symptoms that follow opiate use cessation.
AuthorsJudith S Rose, Marc Branchey, Leah Wallach, Laure Buydens-Branchey
JournalThe American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions (Am J Addict) 2003 May-Jun Vol. 12 Issue 3 Pg. 253-9 ISSN: 1055-0496 [Print] United States
PMID12851021 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Narcotics
  • Serotonin Receptor Agonists
  • Buspirone
  • Methadone
Topics
  • Adult
  • Buspirone (pharmacology)
  • Double-Blind Method
  • Heroin Dependence (rehabilitation)
  • Hospitalization
  • Humans
  • Male
  • Methadone (adverse effects, therapeutic use)
  • Middle Aged
  • Narcotics (adverse effects, therapeutic use)
  • Serotonin Receptor Agonists (pharmacology)
  • Severity of Illness Index
  • Substance Withdrawal Syndrome (drug therapy, etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: